Literature DB >> 6661344

The QT interval and cycle length: the influence of atropine, hyoscine and exercise.

D H Staniforth.   

Abstract

Twenty-seven healthy male subjects of mean age 24.3 +/- 4.0 years and mean weight 74.9 +/- 9.1 kg took part in an investigation to assess the most suitable correction for the QT interval as a function of cardiac cycle length. 547 sets of data points were generated. Atropine 0.6, 1.2 and 1.8 mg, and hyoscine 0.4 and 0.8 mg, and exercise on a bicycle ergometer at power levels of 50-250 watts together with post-exercise values were employed to obtain a range of heart rates. Simultaneous measurement of cardiac output and total peripheral resistance were made. It was found that the traditional square root formula gave an unsatisfactory correction for the QT for supine subjects following atropine and hyoscine. The formula K = QT/RRN was linearized and fitted to the data by the least squares method and gave a best fit correction with N = 0.35, which is close to the cube root correction of Fridericia (1920). Neither stroke volume nor total peripheral resistance were found to provide a further enhancement of the correction. The relationship between QT and cycle length following the exercise protocol was found to be best represented by Bazett's correction but the complex changes in the QT produced by exercise were noted. These findings support the suggestion that either the cube root correction or the best fit correction with N = 0.35 provides a better correction factor than the traditional square root correction for the QT interval in clinical pharmacology experiments for data generated in resting patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661344      PMCID: PMC1428357          DOI: 10.1111/j.1365-2125.1983.tb02230.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  The normal Q-T interval.

Authors:  E SIMONSON; L D CADY; M WOODBURY
Journal:  Am Heart J       Date:  1962-06       Impact factor: 4.749

2.  OBSERVATIONS ON THE CHANGE OF VENTRICULAR SYSTOLE (QT INTERVAL) DURING EXERCISE.

Authors:  P N Yu; R A Bruce; F W Lovejoy; R Pearson
Journal:  J Clin Invest       Date:  1950-03       Impact factor: 14.808

3.  The effect of haematocrit on the resistivity of human blood at 37 degrees C and 100 kHz.

Authors:  D W Hill; F D Thompson
Journal:  Med Biol Eng       Date:  1975-03

4.  Earlier onset of QRS in anterior precordial ECG leads: precision of time interval measurements.

Authors:  M D Danzig; T L Robertson; L S Webber; G Day; D S Dock
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

5.  Adrenergic effects of the QT interval of the electrocardiogram.

Authors:  J A Abildskov
Journal:  Am Heart J       Date:  1976-08       Impact factor: 4.749

6.  QT corrected for heart rate: a new approach and its application.

Authors:  R D Schoenwald; V E Isaacs
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-09

7.  Use of the systolic time intervals in clinical pharmacology.

Authors:  D G Gibson
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

8.  Linear relationship between electrical systole, mechanical systole, and heart rate.

Authors:  H Boudoulas; P Geleris; R P Lewis; S E Rittgers
Journal:  Chest       Date:  1981-11       Impact factor: 9.410

9.  Preeminence of the left stellate ganglion in the long Q-T syndrome.

Authors:  R Crampton
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

10.  Influence of heart rate and inhibition of autonomic tone on the QT interval.

Authors:  S Ahnve; H Vallin
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

View more
  6 in total

1.  Prolongation of the QT interval by ketanserin.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

2.  Correction equation for ECG time intervals.

Authors:  A W Kelman; B Whiting; D J Summer
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

3.  Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem.

Authors:  J Leboeuf; J C Lamar; R Massingham; J Ponsonnaille
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  Relation of human cardiac action potential duration to the interval between beats: implications for the validity of rate corrected QT interval (QTc).

Authors:  W A Seed; M I Noble; P Oldershaw; R B Wanless; A J Drake-Holland; D Redwood; S Pugh; C Mills
Journal:  Br Heart J       Date:  1987-01

5.  Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?

Authors:  D W Harron; D P Nicholls; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

6.  Poisoning with 2,4-dichlorophenoxyacetic acid treated by hemodialysis.

Authors:  Z Durakovic; A Durakovic; S Durakovic; D Ivanovic
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.